Follow The Filings

IBEX

Earnings company data as of 7:59 AM ET 10/23

  • 1 of 1 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS — — —
Rev — — —
FY2027 Q1 10 Sep EPS 0.85 0.85 Beat +0.6%
Rev $168.6M $164.3M Miss -2.5%

Insider trades

Open-market buys and sales by IBEX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All IBEX insider trades
  • None no insider bought on the open market
  • $3.6M sold by 9 insiders outside a trading plan
  • $2.3M sold by 3 insiders under 10b5-1 plans
  1. Robert Thomas Dechant CEO
    Planned sale
    $225K 5,000 shares at $45.02 1.9% of stake
    Traded Sep 25 Filed Sep 29
    ↗
  2. Mingzhe Zhuang Director
    Sale
    $221K 5,522 shares at $40.10 66% of stake
    Traded Sep 15 Filed Sep 16
    ↗
  3. Paul Joseph Inson Chief People Officer
    Sale
    $100K 2,500 shares at $40.07 8.4% of stake
    Traded Sep 16 Filed Sep 16
    ↗
  4. Julie K Casteel Chief Sales/Marketing Officer
    Sale
    $706K 17,474 shares at $40.41 15% of stake
    Traded Sep 15 Filed Sep 16
    ↗
  5. Daniella Ballou-Aares Director
    Sale
    $60K 1,500 shares at $40.29 13% of stake
    Traded Sep 15 Filed Sep 16
    ↗
  6. Christina Alice Trofimuk-O'Connor Chief Legal Officer
    Sale
    $396K 9,876 shares at $40.07 27% of stake
    Traded Sep 15–16 Filed Sep 16
    ↗
  7. Robert Thomas Dechant CEO
    Sale
    $1M 25,000 shares at $39.99 8.7% of stake
    Traded Sep 15 Filed Sep 16
    ↗
  8. Paul Joseph Inson Chief People Officer
    Planned sale
    $91K 2,274 shares at $40.00 7.1% of stake
    Traded Sep 14 Filed Sep 15
    ↗
  9. David Martin Afdahl COO
    Planned sale
    $433K 10,819 shares at $40.07 7.7% of stake
    Traded Sep 14 Filed Sep 15
    ↗
  10. David Martin Afdahl COO
    Planned sale
    $649K 17,500 shares at $37.09 11% of stake
    Traded Sep 8 Filed Sep 10
    ↗
  11. Julie K Casteel Chief Sales/Marketing Officer
    Sale
    $110K 3,600 shares at $30.61 3% of stake
    Traded Jun 11 Filed Jun 16
    ↗
  12. Patrick McGinnis Director
    Sale
    $33K 1,030 shares at $31.69 15% of stake
    Traded May 28 Filed May 29
    ↗
  13. Bruce Neil Dawson Chief Sales and CS Officer
    Sale
    $577K 18,389 shares at $31.40 23% of stake
    Traded May 11–12 Filed May 13
    ↗
  14. Robert Thomas Dechant CEO
    Sale
    $238K 7,800 shares at $30.50 2.7% of stake
    Traded May 13 Filed May 13
    ↗
  15. Daniella Ballou-Aares Director
    Sale
    $163K 6,500 shares at $25.05 38% of stake
    Traded Mar 13, 2025–Dec 2, 2025 Filed Apr 17
    ↗

Also filed in the last 12 months, not counted as buying or selling: 47 stock grants, 32 share withholdings for taxes, 3 other transactions, 1 option exercise, and 1 sale to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 3 shown.

Filed Form Detail Links
10-K Filing Doc
8-K 1.01,2.02,2.03,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.